Journal Club: Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy
This course was designed to educate staff members on the outcomes from clinical trials and other treatment options for patients.
After completing this event, the learner will be able to:
- Verbalize the incidence, disease progression, and treatment options for SMA-1.2.
- Describe the safety and efficacy outcomes of the START study
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance